CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding
Open Access
- 5 August 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 95 (3), 298-306
- https://doi.org/10.1038/sj.bjc.6603222
Abstract
In order to identify potential markers of renal cancer, the plasma membrane protein content of renal cell carcinoma (RCC)-derived cell lines was annotated using a proteomics process. One unusual protein identified at high levels in A498 and 786-O cells was CD70 (TNFSF7), a type II transmembrane receptor normally expressed on a subset of B, T and NK cells, where it plays a costimulatory role in immune cell activation. Immunohistochemical analysis of CD70 expression in multiple carcinoma types demonstrated strong CD70 staining in RCC tissues. Metastatic tissues from eight of 11 patients with clear cell RCC were positive for CD70 expression. Immunocytochemical analysis demonstrated that binding of an anti-CD70 antibody to CD70 endogenously expressed on the surface of A498 and 786-O cell lines resulted in the rapid internalisation of the antibody–receptor complex. Coincubation of the internalising anti-CD70 antibody with a saporin-conjugated secondary antibody before addition to A498 cells resulted in 50% cell killing. These data indicate that CD70 represents a potential target antigen for toxin-conjugated therapeutic antibody treatment of RCC.Keywords
This publication has 49 references indexed in Scilit:
- Dipeptide-based highly potent doxorubicin antibody conjugatesBioorganic & Medicinal Chemistry Letters, 2006
- CD70: A NEW TUMOR SPECIFIC BIOMARKER FOR RENAL CELL CARCINOMAJournal of Urology, 2005
- Induction of T-cell antitumor immunity and protection against tumor growth by secretion of soluble human CD70 moleculesCancer Gene Therapy, 2004
- Comprehensive Proteomic Analysis of Breast Cancer Cell Membranes Reveals Unique Proteins with Potential Roles in Clinical CancerPublished by Elsevier BV ,2003
- Tumour necrosis factor‐α induced CD70 and interleukin‐7R mRNA expression in BEAS‐2B cellsEuropean Respiratory Journal, 2002
- CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumorsInternational Journal of Cancer, 2002
- Induction of tumor-specific T cell memory by NK cell–mediated tumor rejectionNature Immunology, 2001
- Constitutive CD27/CD70 Interaction Induces Expansion of Effector-Type T Cells and Results in IFNγ-Mediated B Cell DepletionImmunity, 2001
- CD27/CD70 interaction directly drives B cell IgG and IgM synthesisEuropean Journal of Immunology, 1995
- CD27–CD70 Interaction: Unravelling its Implication in Normal and Neoplastic B-Cell GrowthLeukemia & Lymphoma, 1995